BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2019 7:02:25 AM | Browse: 1154 | Download: 2105
 |
Received |
|
2019-05-08 04:14 |
|
Peer-Review Started |
|
2019-05-10 02:44 |
|
First Decision by Editorial Office Director |
|
2019-07-31 03:54 |
|
Return for Revision |
|
2019-08-02 07:13 |
|
Revised |
|
2019-08-09 19:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-09-12 10:20 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-09-13 15:49 |
|
Articles in Press |
|
2019-09-13 15:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-10-31 05:40 |
|
Publish the Manuscript Online |
|
2019-12-31 07:02 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019 Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jonathan D Mizrahi, Valerie Gunchick, Kabir Mody, Lianchun Xiao, Phani Keerthi Surapaneni, Rachna T Shroff and Vaibhav Sahai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jonathan D Mizrahi, MD, Academic Fellow, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 463, Houston, TX 77030, United States. jdmizrahi@mdanderson.org |
| Key Words |
Biliary tract neoplasms; Fluorouracil; Irinotecan; Cholangiocarcinoma; Retrospective studies; |
| Core Tip |
We retrospectively analysed patients with advanced biliary tract cancers treated with 5-fluorouracil plus irinotecan at three institutions, MD Anderson, University of Michigan and Mayo Clinic in Jacksonville. We identified 98 patients with a median age of 60 years, most of whom (72%) had intrahepatic cholangiocarcinoma. Fifty and 36 patients were treated in the second and third-line settings, respectively. The median progression-free survival and overall survival were 2.4 (95%CI: 1.7-3.1) and 6.6 (95%CI: 4.7-8.4) mo, respectively. |
| Publish Date |
2019-12-31 07:02 |
| Citation |
Mizrahi JD, Gunchick V, Mody K, Xiao L, Surapaneni P, Shroff RT, Sahai V. Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers. World J Gastrointest Oncol 2020; 12(1): 83-91
|
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i1/83.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i1.83 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
